Navigation Links
NYC Trains Delayed Due to Fainting Dieters

According to a recent analysis by Metropolitan Transportation Authority, Sick subway passengers who faint from dizziness due to excessive dieting are among the top// causes, after the track works and signal problems, for the delay in US subway.

Asim Nelson, a transit emergency medical technician said that Subway-Disruptions Analysis of MTA statistics, taken between October 2005 and October 2006, shows that fainting dieters topped the "sick customer" list. Nelson is part of the MTA's "sick Customer Response Program," which consists of emergency medical technicians and registered nurses.

"Not eating for three or four days, you are going to go down and if you don't eat for 12 hours, you are going to get weak." – He added.

The newspaper Metro had earlier reported in its 2005 – article, reported the notion that fainting dieters are causing transit delays.

Though the agency did not keep any official record of the nature of each passenger's illness, the paper said that an average of 395 delays each month are caused by the sick customers. Other reasons for fainting would be due to flu symptoms, anxiety attacks, hangovers, heat exhaustion etc., - Nelson added.
SR
'"/>




Page: 1

Related medicine news :

1. Peripheral Artery Disease Can Be Delayed By Walking
2. Search For Bigfoot Creature To Be Delayed
3. Planning Permission Delayed In Scotland
4. Delayed Start By Niger On Culling Of Poultry
5. Delayed Drug In New Zealand Markets
6. Toddlers Delayed Speech not Due to Parenting Faults
7. Test of Patience: Surgery Delayed is Surgery Denied?
8. Dementia Delayed by the Capacity to Speak Two Languages
9. Home-going Delayed for Miracle Baby
10. ‘Delayed Reaction’ to Radiation Therapy Takes the Life of a Woman After 30 Yeas
11. Delayed Cutting of Umbilical Cord Has Benefits
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NYC Trains Delayed Due Fainting Dieters

(Date:10/8/2008)... , Dr. Robert Bernstein, ...rocedure for hair restoration is featured on the O...atment. , New York, NY (P...atures Dr. Bernstein discussing his pioneering fol...n the newest diagnostic and treatment techniques f...
(Date:10/7/2008)... U.S. recommendations reflect previously publ...LAS, Oct. 7 /PRNewswire-USNewswire/ -- Guidelines,...epartment of Health and,Human Services (HHS) were ...ts Medicine (ACSM) and the American Heart Associat...hed physical activity recommendations,last year, a...
(Date:10/7/2008)ANAHEIM, Calif., Oct. 7 /PRNewswire-USNewswire/ -- CHADD, the nation,s,largest organization serving people affected by AD/HD, will hold its Annual,International Conference on AD/HD November 12-1
(Date:10/7/2008)... Compression ultrasound similar to more expensive... , TUESDAY, Oct. 7 (HealthDay News) -- An o...leg -- called deep vein thrombosis, or DVT -- is a...esearch says. , European researchers found that...alled compression or duplex ultrasound -- was as g...
Breaking Medicine News(10 mins):Health News:Pioneering Hair Transplant Doctor Explains Procedure on Oprah Winfrey Show 2Health News:ACSM, AHA Support Federal Physical Activity Guidelines 2Health News:ACSM, AHA Support Federal Physical Activity Guidelines 3Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
...are commonly used for a number of painful complai... attack and stroke//. This has lead to an order by...rugs will have to carry a warning along with the i...turers. Doctors are being informed of the small ...
...nt study, women with a twin are at upto 5 times hi...an those without one//. The study was conducted o... The risk of premature ovarian failure (POF) at th...s than women from the general population. POF caus...
...lie Minogue with breast cancer has led to confusio...o get breast cancer//. Cancer Research UK said t...re likely to strike the under-70s than women over ...en revealed that 77 per cent of them thought that ...
...safe for administration in babies and toddlers, re...of flu shots//. Two flu seasons back, the federal...the age 6 months to 2 years and their family membe...ise in the number of children getting vaccinated. ...
Other Medicine News:
(Date:10/7/2008)... VIENNA, Va., Oct. 7 /...y that it has entered into a Material Transfer,Agr...h Clinical Center,(NIHCC) and the laboratory of Dr... molecular basis of changes to the tumor microenvi... Dr. Marincola is the Chief of,the Infectious Dise...
(Date:10/7/2008)... - Data Presented Today at ACG Annual Sc...wire-FirstCall/ -- Ironwood,Pharmaceuticals, Inc. ...,Inc. (NYSE: FRX ) today announced the presentati...clotide,s safety and efficacy in 420 patients with...). Analysis of the data,indicates that once- daily...
(Date:10/7/2008)... Several abstracts highlighting CIMZIA,s long...hn,s disease patients presented at American Colleg... /- Data from two studies,p...of Gastroenterology,(ACG) Annual Meeting demonstra...PEGylated anti-TNF alpha (Tumor Necrosis Factor al...
(Date:10/7/2008)... - Planned 15 Patient Cohort Enrolled in Stage A...ombination With Carboplatin and Paclitaxel -, TUS...grine,Pharmaceuticals, Inc. (Nasdaq: PPHM ), a cl...monoclonal antibodies for the treatment of cancer ...nced that it has completed,enrollment in the first...
Breaking Medicine Technology:CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4Doctors See How Cancer Drug Can Damage Kidneys 14210 1Doctors See How Cancer Drug Can Damage Kidneys 14210 2Doctors See How Cancer Drug Can Damage Kidneys 14210 3New Tools Boost Alzheimers Awareness 14206 1New Tools Boost Alzheimers Awareness 14206 2New Tools Boost Alzheimers Awareness 14206 3WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 1WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 2WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 3WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 4WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 5WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 6WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 7WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 8WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 9WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 10WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 11WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3916 12The Makers of Conquer HA 28TM 29 Launch All Natural Double Strength Anti Inflammatory Formula 14200 1The Makers of Conquer HA 28TM 29 Launch All Natural Double Strength Anti Inflammatory Formula 14200 2
The 6303 is an affordable path to Sonesta flexibility. Three motors provide full height, seat, and back adjustments. Packaged with basic accessories, the 6303 accepts the full line of Sonesta add-ons
For complete unobstructed imaging coverage for a wide range of urological procedures, HealthTronics urodynamics Chair/Table is the answer.
The Advanced Model BR2 Bilirubin STAT-Analyzer® provides a rapid, accurate determination of total and direct bilirubin in neonates. And because it's so compact and easy to use, it is appropriate
...e utilises a generic PCR amplification with biotin...on of an HLA locus. This is followed by hybridisat...nce Specific Oligonucleotide probes immobilised on...bes is referred to as a Reverse Line blot and thus...
Medicine Products: